Cover Page
Cover Page - shares | 6 Months Ended | |
Dec. 31, 2021 | Jan. 31, 2022 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Dec. 31, 2021 | |
Document Transition Report | false | |
Entity File Number | 001-39058 | |
Entity Registrant Name | Peloton Interactive, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 47-3533761 | |
Entity Address, Address Line One | 441 Ninth Avenue, Sixth Floor | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10001 | |
City Area Code | 917 | |
Local Phone Number | 671-9198 | |
Title of 12(b) Security | Class A common stock, $0.000025 par value per share | |
Trading Symbol | PTON | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false | |
Entity Central Index Key | 0001639825 | |
Current Fiscal Year End Date | --06-30 | |
Class A Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 302,996,134 | |
Class B Common Stock | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 28,604,062 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2021 | Jun. 30, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 1,606.9 | $ 1,134.8 |
Marketable securities | 0 | 472 |
Accounts receivable, net | 94.7 | 71.4 |
Inventories, net | 1,541.3 | 937.1 |
Prepaid expenses and other current assets | 213.7 | 202.8 |
Total current assets | 3,456.6 | 2,818.1 |
Property and equipment, net | 737.6 | 591.9 |
Intangible assets, net | 229.2 | 247.9 |
Goodwill | 224.4 | 210.1 |
Restricted cash | 87.7 | 0.9 |
Operating lease right-of-use assets, net | 705.5 | 580.1 |
Other assets | 41.6 | 36.7 |
Total assets | 5,482.5 | 4,485.6 |
Current liabilities: | ||
Accounts payable and accrued expenses | 1,136 | 989.1 |
Customer deposits and deferred revenue | 240.5 | 164.8 |
Operating lease liabilities, current | 80.8 | 61.9 |
Other current liabilities | 24.4 | 27.2 |
Total current liabilities | 1,481.7 | 1,243 |
Convertible senior notes, net | 846.7 | 829.8 |
Operating lease liabilities, non-current | 743.7 | 620.4 |
Other non-current liabilities | 41.5 | 38.3 |
Total liabilities | 3,113.6 | 2,731.5 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity | ||
Common stock, $0.000025 par value; 2,500,000,000 and 2,500,000,000 Class A shares authorized, 302,778,818 and 270,855,356 shares issued and outstanding as of December 31, 2021 and June 30, 2021, respectively; 2,500,000,000 and 2,500,000,000 Class B shares authorized, 28,668,327 and 29,291,774 shares issued and outstanding as of December 31, 2021 and June 30, 2021, respectively. | 0 | 0 |
Additional paid-in capital | 4,048.8 | 2,618.9 |
Accumulated other comprehensive income | 18.3 | 18.2 |
Accumulated deficit | (1,698.2) | (883) |
Total stockholders’ equity | 2,368.9 | 1,754.1 |
Total liabilities and stockholders’ equity | $ 5,482.5 | $ 4,485.6 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2021 | Jun. 30, 2021 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.000025 | $ 0.000025 |
Common stock, shares authorized (in shares) | 2,500,000,000 | 2,500,000,000 |
Common stock, shares issued (in shares) | 302,778,818 | 270,855,356 |
Common stock, shares outstanding (in shares) | 302,778,818 | 270,855,356 |
Class B Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.000025 | $ 0.000025 |
Common stock, shares authorized (in shares) | 2,500,000,000 | 2,500,000,000 |
Common stock, shares issued (in shares) | 28,668,327 | 29,291,774 |
Common stock, shares outstanding (in shares) | 28,668,327 | 29,291,774 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue | $ 1,133.9 | $ 1,064.8 | $ 1,939.1 | $ 1,822.7 |
Cost of revenue | 853.7 | 640 | 1,396.2 | 1,069.2 |
Gross profit | 280.2 | 424.8 | 543 | 753.5 |
Operating expenses: | ||||
Sales and marketing | 349.6 | 177.4 | 633.9 | 292.1 |
General and administrative | 248.7 | 141.1 | 489 | 249.7 |
Research and development | 100 | 47.5 | 197.7 | 84.1 |
Impairment expense | 7.7 | 0 | 7.7 | 0 |
Total operating expenses | 705.9 | 366 | 1,328.3 | 625.8 |
(Loss) income from operations | (425.7) | 58.8 | (785.4) | 127.7 |
Other (expense) income, net: | ||||
Interest expense | (8.8) | (0.4) | (17.4) | (0.8) |
Interest income | 0.3 | 2.3 | 0.9 | 5.1 |
Foreign exchange losses | (1.7) | (0.1) | (7.6) | (0.8) |
Other expense, net | (0.4) | 0 | (0.4) | 0 |
Total other (expense) income, net | (10.6) | 1.8 | (24.6) | 3.5 |
(Loss) income before provision for income taxes | (436.3) | 60.6 | (809.9) | 131.2 |
Income tax expense (benefit) | 3.1 | (3) | 5.4 | (1.7) |
Net (loss) income | (439.4) | 63.6 | (815.3) | 132.8 |
Net (loss) income attributable to Class A and Class B common stockholders | $ (439.4) | $ 63.6 | $ (815.3) | $ 132.8 |
Net (loss) income per share attributable to common stockholders, basic (in dollars per share) | $ (1.39) | $ 0.22 | $ (2.64) | $ 0.46 |
Net (loss) income per share attributable to common stockholders, diluted (in dollars per share) | $ (1.39) | $ 0.18 | $ (2.64) | $ 0.39 |
Weighted-average Class A and Class B common shares outstanding, basic (in shares) | 317,110,297 | 292,462,184 | 309,119,648 | 290,591,037 |
Weighted-average Class A and Class B common shares outstanding, diluted (in shares) | 317,110,297 | 347,886,695 | 309,119,648 | 344,994,314 |
Other comprehensive income: | ||||
Net unrealized losses on marketable securities | $ (0.5) | $ 0 | $ (0.4) | $ (2.6) |
Change in foreign currency translation adjustment | (0.2) | (1.3) | 2.1 | 9.1 |
Net unrealized loss on hedging derivatives | 1.9 | 5.3 | (1.5) | 0 |
Total other comprehensive income | 1.2 | 4 | 0.1 | 6.5 |
Comprehensive (loss) income | (438.2) | 67.5 | (815.2) | 139.4 |
Connected Fitness Products | ||||
Revenue | 796.4 | 870.1 | 1,297.4 | 1,471.5 |
Cost of revenue | 745.5 | 562.8 | 1,186.2 | 927 |
Subscription | ||||
Revenue | 337.5 | 194.7 | 641.7 | 351.2 |
Cost of revenue | $ 108.3 | $ 77.2 | $ 210 | $ 142.2 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 6 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Cash Flows from Operating Activities: | ||
Net (loss) income | $ (815.3) | $ 132.8 |
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
Depreciation and amortization expense | 64.2 | 24.2 |
Stock-based compensation expense | 124.8 | 67.1 |
Non-cash operating lease expense | 41.7 | 28.2 |
Amortization of premium from marketable securities | 3.4 | 3.5 |
Amortization of debt discount and issuance costs | 17.1 | 0.2 |
Impairment expense | 7.7 | 0 |
Net foreign currency adjustments | 6.9 | 0 |
Loss (gain) on disposals | 2.3 | 2.1 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (23.4) | (18) |
Inventories | (601.5) | (273) |
Prepaid expenses and other current assets | (50.8) | (35.2) |
Other assets | (8.4) | 0.7 |
Accounts payable and accrued expenses | 172.2 | 331.9 |
Customer deposits and deferred revenue | 75.8 | 245.7 |
Operating lease liabilities, net | (24.9) | 4.1 |
Other liabilities | 0.6 | (3.9) |
Net cash (used in) provided by operating activities | (1,007.6) | 510.5 |
Cash Flows from Investing Activities: | ||
Purchases of marketable securities | 0 | (449.1) |
Maturities of marketable securities | 211 | 300.6 |
Sales of marketable securities | 306.7 | 0 |
Purchases of property and equipment | (178.4) | (119.4) |
Business combinations, net of cash acquired | (11) | 0 |
Asset acquisitions, net of cash acquired | (16) | (78.1) |
Internal-use software costs and other | (12.7) | (0.7) |
Net cash provided by (used in) investing activities | 299.6 | (346.7) |
Cash Flows from Financing Activities: | ||
Proceeds from public offering, net of issuance costs | 1,218.8 | 0 |
Proceeds from employee stock purchase plan withholdings | 15.2 | 7.2 |
Proceeds from exercise of stock options | 54.2 | 53.3 |
Taxes withheld and paid on employee stock awards | 0 | (16.5) |
Principal repayments of finance leases | (1) | (0.5) |
Net cash provided by financing activities | 1,287.2 | 43.6 |
Effect of exchange rate changes | (20.3) | 5.5 |
Net change in cash, cash equivalents, and restricted cash | 558.9 | 212.9 |
Cash, cash equivalents, and restricted cash — Beginning of period | 1,135.7 | 1,037 |
Cash, cash equivalents, and restricted cash — End of period | 1,694.6 | 1,249.9 |
Supplemental Disclosures of Cash Flow Information: | ||
Cash paid for interest | 0.5 | 0.3 |
Cash paid for income taxes | 9.1 | 1.3 |
Supplemental Disclosures of Non-Cash Investing and Financing Information: | ||
Property and equipment accrued but unpaid | 36 | 47.2 |
Stock-based compensation capitalized for software development costs | $ 5.1 | $ 1.8 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Millions | Total | Common StockClass A and Class B Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income | Accumulated Deficit |
Beginning balance (in shares) at Jun. 30, 2020 | 288,100,000 | ||||
Beginning balance at Jun. 30, 2020 | $ 1,678 | $ 0 | $ 2,361.8 | $ 10.1 | $ (693.9) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Activity related to stock-based compensation (in shares) | 5,900,000 | ||||
Activity related to stock-based compensation | 105.8 | 105.8 | |||
Issuance of common stock under employee stock purchase plan (in shares) | 200,000 | ||||
Issuance of common stock under employee stock purchase plan | 5.1 | 5.1 | |||
Other comprehensive income | 6.5 | 6.5 | |||
Net (loss) income | 132.8 | 132.8 | |||
Ending balance (in shares) at Dec. 31, 2020 | 294,300,000 | ||||
Ending balance at Dec. 31, 2020 | 1,928.3 | $ 0 | 2,472.7 | 16.6 | (561) |
Beginning balance (in shares) at Sep. 30, 2020 | 291,800,000 | ||||
Beginning balance at Sep. 30, 2020 | 1,801 | $ 0 | 2,412.9 | 12.7 | (624.6) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Activity related to stock-based compensation (in shares) | 2,400,000 | ||||
Activity related to stock-based compensation | 59.9 | 59.9 | |||
Other comprehensive income | 4 | 4 | |||
Net (loss) income | 63.6 | 63.6 | |||
Ending balance (in shares) at Dec. 31, 2020 | 294,300,000 | ||||
Ending balance at Dec. 31, 2020 | 1,928.3 | $ 0 | 2,472.7 | 16.6 | (561) |
Beginning balance (in shares) at Jun. 30, 2021 | 300,100,000 | ||||
Beginning balance at Jun. 30, 2021 | 1,754.1 | $ 0 | 2,618.9 | 18.2 | (883) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Activity related to stock-based compensation (in shares) | 3,800,000 | ||||
Activity related to stock-based compensation | 199.5 | 199.5 | |||
Issuance of common stock under employee stock purchase plan (in shares) | 300,000 | ||||
Issuance of common stock under employee stock purchase plan | 11.7 | 11.7 | |||
Issuance of common stock pursuant to public offering, net of issuance costs (in shares) | 27,200,000 | ||||
Issuance of common stock pursuant to public offering, net of issuance costs | 1,218.7 | 1,218.7 | |||
Other comprehensive income | 0.1 | 0.1 | |||
Net (loss) income | (815.3) | (815.3) | |||
Ending balance (in shares) at Dec. 31, 2021 | 331,400,000 | ||||
Ending balance at Dec. 31, 2021 | 2,368.9 | $ 0 | 4,048.8 | 18.3 | (1,698.2) |
Beginning balance (in shares) at Sep. 30, 2021 | 302,800,000 | ||||
Beginning balance at Sep. 30, 2021 | 1,506.9 | $ 0 | 2,748.6 | 17.1 | (1,258.8) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
Activity related to stock-based compensation (in shares) | 1,500,000 | ||||
Activity related to stock-based compensation | 81.5 | 81.5 | |||
Issuance of common stock pursuant to public offering, net of issuance costs (in shares) | 27,200,000 | ||||
Issuance of common stock pursuant to public offering, net of issuance costs | 1,218.7 | 1,218.7 | |||
Other comprehensive income | 1.2 | 1.2 | |||
Net (loss) income | (439.4) | (439.4) | |||
Ending balance (in shares) at Dec. 31, 2021 | 331,400,000 | ||||
Ending balance at Dec. 31, 2021 | $ 2,368.9 | $ 0 | $ 4,048.8 | $ 18.3 | $ (1,698.2) |
Description of Business and Bas
Description of Business and Basis of Presentation | 6 Months Ended |
Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Business and Basis of Presentation | Description of Business and Basis of Presentation Description and Organization Peloton Interactive, Inc. (“Peloton” or the “Company”) is the largest interactive fitness platform in the world with a loyal community of Members, which we define as any individual who has a Peloton account through a paid Connected Fitness Subscription or a paid Peloton Digital Subscription. The Company pioneered connected, technology-enabled fitness with the creation of its interactive fitness equipment (“Connected Fitness Products”) and the streaming of immersive, instructor-led boutique classes to its Members anytime, anywhere. The Company makes fitness entertaining, approachable, effective, and convenient while fostering social connections that encourage Members to be the best versions of themselves. Basis of Presentation and Consolidation The accompanying interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet as of June 30, 2021, included herein, was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on August 27, 2021 (the “Form 10-K”). However, the Company believes that the disclosures provided herein are adequate to prevent the information presented from being misleading. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, the accompanying interim condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, cash flows, and the changes in equity for the interim periods. The results for the three and six months ended December 31, 2021 are not necessarily indicative of the results to be expected for any subsequent quarter, the fiscal year ending June 30, 2022, or any other period. Certain monetary amounts, percentages, and other figures included elsewhere in these financial statements have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the percentages that precede them. Except as described elsewhere in Note 2 - Summary of Significant Accounting Policies of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q under the heading “Recently Issued Accounting Pronouncements” , there have been no material changes to the Company’s significant accounting policies as described in the Form 10-K. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 6 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Use of Estimates The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, content costs for past use reserve, fair value measurements, the incremental borrowing rate associated with lease liabilities, impairment of long-lived and intangible assets, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, goodwill, accounting for income taxes, stock-based compensation expense, transaction price estimates, the fair values of assets acquired and liabilities assumed in business combinations and asset acquisitions, valuation of the debt component of convertible senior notes, contingent consideration, and commitments and contingencies. Actual results may differ from these estimates. Derivative Instruments and Hedging Activities Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of foreign currency exchange risk. As required by ASC 815, the Company records all derivatives on the balance sheet at fair value in the following line items: Prepaid expenses and other current assets; and Other current liabilities. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. The Company does not currently have fair value or net investment hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. In addition to our derivatives where we apply hedge accounting, the Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company’s financial statements in accordance with the criteria under ASC 815-15. As of December 31, 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. Recently Issued Accounting Pronouncements Accounting Pronouncements Recently Adopted ASU 2020-01 In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance clarifies the interaction of the accounting for equity investments under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. This standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company has completed its assessment and adopted this standard on July 1, 2021. The adoption of this standard did not materially impact the Company’s condensed consolidated financial statements. ASU 2020-04 and ASU 2021-01 In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848) , which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU 2021-01 are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The guidance in both updates was effective upon issuance and generally can be applied through December 31, 2022. The Company adopted this standard after LIBOR was discontinued on December 31, 2021. The adoption of this standard did not materially impact the Company's condensed consolidated financial statements. Accounting Pronouncements Not Yet Adopted ASU 2020-06 In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity . The guidance will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock, thereby limiting the accounting results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, the guidance eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Upon adoption, the Company expects a decrease to Additional paid-in capital to remove the equity component separately recorded for the conversion features associated with the Notes (as defined in Note 7 - Debt of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q), an increase in the carrying value of its Notes to reflect the full principal amount of the Notes outstanding net of issuance costs, and an increase to Accumulated deficit. The Company expects the adoption of this standard to reduce its reported Interest expense. ASU 2021-08 In October 2021, the Financial Accounting Standards Board issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The guidance requires that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . This standard is effective for annual periods beginning after December 15, 2022, including interim periods therein, with early adoption permitted, and should be applied prospectively to acquisitions occurring on or after the effective date. The Company will continue to evaluate the impact of this guidance, which will depend on the contract assets and liabilities acquired in future business combinations. |
Revenue
Revenue | 6 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue The Company’s primary source of revenue is from sales of its Connected Fitness Products and associated recurring Subscription revenues. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s revenue is reported net of sales returns, discounts, incentives, and rebates to commercial distributors as a reduction of the transaction price. Certain contracts include consideration payable that is accounted for as a payment for distinct goods or services. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. Some of the Company’s contracts with customers contain multiple performance obligations. For customer contracts that include multiple performance obligations, the Company accounts for individual performance obligations if they are distinct. The transaction price is then allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the prices charged to customers. The Company applies the practical expedient as per ASC 606-10-50-14 and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Connected Fitness Products Connected Fitness Products include the Company’s portfolio of Connected Fitness Products and related accessories, Precor branded fitness products, delivery and installation services, Peloton branded apparel, extended warranty agreements, and commercial service contracts. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period and service revenue which is recognized over the term of the service contract. The Company allows customers to return Peloton branded Connected Fitness Products within thirty days of purchase, as stated in its return policy. The Company records fees paid to third-party financing partners in connection with its consumer financing program as a reduction of revenue, as it considers such costs to be a customer sales incentive. The Company records payment processing fees for its credit card sales for Connected Fitness Products within Sales and marketing in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Subscription The Company’s subscriptions provide unlimited access to content in its library of live and on-demand fitness classes. The Company’s subscriptions are offered on a month-to-month basis. Amounts paid for subscription fees, net of refunds are included within Customer deposits and deferred revenue on the Company’s condensed consolidated balance sheets and recognized ratably over the subscription term. The Company records payment processing fees for its monthly subscription charges within cost of Subscription revenue in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Sales tax collected from customers and remitted to governmental authorities is not included in revenue and is reflected as a liability on the Company’s condensed consolidated balance sheets. Standard Product Warranty The Company offers a standard product warranty that its Connected Fitness Products will operate under normal, non-commercial use for a period of one year covering the touchscreen and most original Bike, Bike+, Tread, and Tread+ components from the date of original delivery. The Company has the obligation, at its option, to either repair or replace the defective product. At the time revenue is recognized, an estimate of future warranty costs are recorded as a component of cost of revenue. Factors that affect the warranty obligation include historical as well as current product failure rates, service delivery costs incurred in correcting product failures, and warranty policies and business practices. The Company’s products are manufactured both in-house and by contract manufacturers, and in certain cases, the Company may have recourse to such contract manufacturers. Activity related to the Company’s accrual for our estimated future product warranty obligation was as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Balance at beginning of period $ 44.4 $ 38.6 $ 51.5 $ 34.2 Provision for warranty accrual 18.8 6.8 26.1 17.5 Warranty claims (14.7) (12.8) (29.1) (19.1) Balance at end of period $ 48.5 $ 32.6 $ 48.5 $ 32.6 The Company also offers the option for customers in some markets to purchase an extended warranty and service contract that extends or enhances the technical support, parts, and labor coverage offered as part of the base warranty included with the Connected Fitness Product for an additional period of 12 to 27 months. Extended warranty revenue is recognized on a gross basis as the Company has a continuing obligation to perform over the service period. Extended warranty revenue is recognized ratably over the extended warranty coverage period and is included in Connected Fitness Product revenue in the condensed consolidated statements of operations and comprehensive (loss) income. Disaggregation of Revenue The Company’s revenue from contracts with customers disaggregated by major product lines, excluding sales-based taxes, are included in Note 13- Segment Information of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q. The Company’s revenue disaggregated by geographic region, were as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) North America $ 1,035.0 $ 1,007.8 $ 1,763.8 $ 1,729.7 International 98.9 57.0 175.3 93.0 Total revenue $ 1,133.9 $ 1,064.8 $ 1,939.1 $ 1,822.7 During the three and six months ended December 31, 2021, the Company’s revenue attributable to the United States was $982.7 million and $1,678.9 million or 87% and 87% of total revenue, respectively. During the three and six months ended December 31, 2020, the Company’s revenue attributable to the United States was $971.4 million and $1,673.7 million or 91% and 92% of total revenue, respectively. Customer Deposits and Deferred Revenue As of December 31, 2021 and June 30, 2021, customer deposits of $159.9 million and $92.2 million, respectively, and deferred revenue of $80.6 million and $72.6 million, respectively, were included in Customer deposits and deferred revenue on the Company’s condensed consolidated balance sheets. In the six months ended December 31, 2021 and 2020, the Company recognized revenue of $64.9 million and $22.1 million, respectively, that was included in the deferred revenue balance as of June 30, 2021 and 2020, respectively. Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Customer deposits represent payments received in advance before the Company transfers a good or service to the customer and are refundable. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements Fair Value Measurements of Other Financial Instruments The following table presents the estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets: As of December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Convertible Senior Notes $ — $ 852.3 $ — $ 852.3 The fair value of the 0% Convertible Senior Notes due February 15, 2026 (the “Notes”) is determined based on the closing price on the last trading day of the reporting period. |
Inventories
Inventories | 6 Months Ended |
Dec. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories Inventories were as follows: December 31, 2021 June 30, 2021 (in millions) Raw materials $ 100.3 $ 109.8 Work-in-process 5.5 7.9 Finished products (1) 1,522.0 879.5 Total inventories 1,627.8 997.2 Less: Reserves (86.5) (60.1) Total inventories, net $ 1,541.3 $ 937.1 _________________________ |
Acquisitions
Acquisitions | 6 Months Ended |
Dec. 31, 2021 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions | Acquisitions Business Combination Precor Incorporated On April 1, 2021, the Company acquired the Precor business, which consisted of 15 legal entities (“Precor”) from Amer Sports Corporation (“Amer”) for a purchase price of approximately $412.0 million, net of cash acquired, which was paid in cash. During the six months ended December 31, 2021, the purchase consideration was reduced by $2.9 million associated with working capital adjustments, resulting in a revised purchase price of $409.2 million. Upon completion of the transaction, Precor became wholly owned subsidiaries of the Company. During the fourth quarter of fiscal 2021, the Company completed a preliminary analysis to determine the fair values of the assets acquired and liabilities assumed and the amounts recorded reflected management’s initial assessment of fair value as of the closing date. Based on additional information obtained to date, the Company refined its initial assessment of fair value and, as a result, recognized the following adjustments to the Company’s preliminary purchase price allocation during the first quarter of fiscal 2022: Inventory decreased $4.0 million, Intangible assets, net increased $1.0 million, and deferred tax liability increased $3.4 million. The adjustments resulted in a corresponding increase to Goodwill of $3.5 million, of which $3.4 million relates to the deferred tax liability and $0.1 million relates to the updated fair value assessment. The adjustments did not result in a material impact on the financial results of prior periods. The Company expects to finalize its purchase price allocation after management has further analyzed and assessed a number of the factors used in establishing the fair values of assets acquired and liabilities assumed as of the acquisition date including, but not limited to, the working capital acquired. The final fair value determination could result in material adjustments to the values presented in the preliminary purchase price allocation. Other Acquisitions During the three and six months ended December 31, 2021, the Company completed two transactions to acquire certain developed software and assembled workforce for use in the development of the Company’s data platform and content supply chain. The transactions were completed on November 1, 2021 and November 8, 2021, and were accounted for as a business combination and asset acquisition, respectively. The acquisitions resulted in the recognition of $12.0 million of Goodwill, and $17.7 million of assets primarily consisting of developed software. The developed software was assigned a useful life of 3 years and is recorded in Property and equipment, net on the Company’s condensed consolidated balance sheets. |
Debt
Debt | 6 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt | Debt Convertible Notes and the Indenture In February 2021, the Company issued $1.0 billion aggregate principal amount of the Notes in a private offering, including the exercise in full of the over-allotment option granted to the initial purchasers of $125.0 million. The Notes were issued pursuant to an Indenture (the “Indenture”) between the Company and U.S. Bank National Association, as trustee. The Notes are senior unsecured obligations of the Company and do not bear regular interest, and the principal amount of the Notes does not accrete. The net proceeds from this offering were approximately $977.2 million, after deducting the initial purchasers' discounts and commissions and the Company’s offering expenses. Each $1,000 principal amount of the Notes is initially convertible into 4.1800 shares of the Company’s Class A Common Stock, which is equivalent to an initial conversion price of approximately $239.23 per share. The conversion rate is subject to customary adjustments under certain circumstances in accordance with the terms of the Indenture. In addition, if certain corporate events that constitute a make-whole fundamental change occur, then the conversion rate will, in certain circumstances, be increased for a specified period of time. The Notes will mature on February 15, 2026, unless earlier converted, redeemed, or repurchased. The Notes will be convertible at the option of the holders at certain times and upon the occurrence of certain events in the future. On or after August 15, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. Upon conversion, the Company may satisfy its conversion obligation by paying and/or delivering, as the case may be, cash, shares of the Class A Common Stock or a combination of cash and shares of the Class A Common Stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. It is the Company’s current intent to settle the principal amount of the Notes with cash. The Company may redeem for cash all or any portion of the Notes, at its option, on or after February 20, 2024 and on or before the 20th scheduled trading day immediately before the maturity date, if the last reported sale price per share of the Class A Common Stock exceeds 130% of the conversion price then in effect on (1) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption and (2) the trading day immediately before the date the Company sends such notice at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid special interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the Notes, which means that the Company is not required to redeem or retire the Notes periodically. Upon the occurrence of a fundamental change (as defined in the Indenture), subject to certain conditions, holders may require the Company to repurchase all or a portion of the Notes for cash at a price equal to 100% of the principal amount of the Notes to be repurchased, plus any accrued and unpaid special interest, if any, to, but excluding, the fundamental change repurchase date. The Notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s existing and future indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of the Company’s existing and future unsecured indebtedness that is not so subordinated; effectively subordinated in right of payment to any of the Company’s existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities of current or future subsidiaries of the Company (including trade payables and to the extent the Company is not a holder thereof, preferred equity, if any, of the Company’s subsidiaries). In accounting for the issuance of the Notes, the Company separated the Notes into liability and equity components, using an effective interest rate of 3.69% to determine the fair value of the liability component. The carrying amount of the equity component representing the conversion option was $163.8 million and was determined by deducting the fair value of the liability component from the initial proceeds ascribed to the Notes as a whole. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (“debt discount”) is amortized to interest expense using the effective interest method over the contractual term of the Notes. In accounting for the transaction costs related to the Notes, the Company allocated the total amount incurred to the liability and equity components of the Notes based on the proportion of the proceeds allocated to the debt and equity components. Issuance costs attributable to the liability component recorded as additional debt discount were $19.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the Notes. Issuance costs attributable to the equity component of $3.7 million were netted with the equity component in stockholders’ equity. The net carrying amount of the liability component of the Notes was as follows: December 31, 2021 (in millions) Principal $ 1,000.0 Unamortized debt discount (137.1) Unamortized debt issuance costs (16.2) Net carrying amount $ 846.7 The following table sets forth the interest expense recognized related to the Notes: Three Months Ended December 31, 2021 Six Months Ended December 31, 2021 (in millions) Amortization of debt discount $ 7.7 $ 15.3 Amortization of debt issuance costs 0.8 1.6 Less: Interest capitalized (0.2) (0.2) Total interest expense related to the Notes $ 8.3 $ 16.7 Capped Call Transactions In connection with the offering of the Notes, the Company entered into privately negotiated capped call transactions with certain counterparties (the “Capped Call Transactions”). The Capped Call Transactions have an initial strike price of approximately $239.23 per share, subject to adjustments, which corresponds to the approximate initial conversion price of the Notes. The cap price of the Capped Call Transactions will initially be approximately $362.48 per share. The Capped Call Transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Notes, 6.9 million shares of Class A Common Stock. The Capped Call Transactions are expected generally to reduce potential dilution to the Class A Common Stock upon any conversion of Notes and/or offset any potential cash payments the Company would be required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. If, however, the market price per share of Class A Common Stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that the then-market price per share of the Class A Common Stock exceeds the cap price of the Capped Call Transactions. For accounting purposes, the Capped Call Transactions are separate transactions, and are not part of the terms of the Notes. The net cost of $81.3 million incurred to purchase the Capped Call Transactions was recorded as a reduction to Additional paid-in capital on the Company’s condensed consolidated balance sheets. Amended and Restated Credit Agreement In 2019, the Company entered into an amended and restated loan and security agreement (“Amended and Restated Credit Agreement”). The Amended and Restated Credit Agreement provided for a $250.0 million secured revolving credit facility, including up to the lesser of $150.0 million and the aggregate unused amount of the facility for the issuance of letters of credit. On February 8, 2021, the Company entered into a First Amendment (the “First Amendment”) to the Amended and Restated Credit Agreement to revise certain covenants that restricted the incurrence of indebtedness to permit the Capped Call Transactions and issuance of the Notes. On March 18, 2021, the Company entered into a Joinder Agreement (the “Joinder”) to the Amended and Restated Credit Agreement, as amended by the First Amendment, to provide for an increase of the commitments available under the revolving credit facility from $250.0 million to $285.0 million. On December 10, 2021, the Company entered into a Second Amendment (the “Second Amendment”) to the Amended and Restated Credit Agreement (as amended by the First Amendment, the Joinder and the Second Amendment, the “Credit Agreement”). The Second Amendment amends certain provisions of the Credit Agreement to, among other changes, increase the lenders’ aggregate commitments to extend credit to the Company from an aggregate amount of $285.0 million in revolving loans to an aggregate amount of $500.0 million in revolving loans, extend the maturity date for $465.0 million of the commitments to December 10, 2026 with $35.0 million of the commitments expiring on June 20, 2024, and modify certain covenants contained therein. Interest on the Amended Credit Agreement is paid based on the Secured Overnight Financing Rate (“SOFR”) plus 2.25% or an Alternative Base Rate plus 1.25% for revolving loans maturing on December 10, 2026, and is paid based on SOFR plus 2.75% or an Alternative Base Rate plus 1.75% for revolving loans maturing on June 20, 2024. The Company is required to pay an annual commitment fee of 0.325% and 0.375% on a quarterly basis based on the unused portion of the revolving credit facility for the revolving loans maturing on December 10, 2026 and June 20, 2024, respectively. During the three and six months ended December 31, 2021, the Company incurred total commitment fees of $0.3 million and $0.6 million, respectively, and $0.2 million and 0.5 million during the three and six months ended December 31, 2020, respectively, which are included in Interest expense in the condensed consolidated statements of operations and comprehensive (loss) income. As of December 31, 2021, the Company had not drawn on the credit facility and did not have outstanding borrowings under the Credit Agreement. In connection with the execution of the Second Amendment, the Company incurred debt issuance costs of $1.1 million which are capitalized and presented as Other assets on the Company’s condensed consolidated balance sheets. These costs are being amortized to interest expense using the effective interest method over the term of the Credit Agreement. The Company has the option to repay its borrowings under the Credit Agreement without premium or penalty prior to maturity. The Credit Agreement contains customary affirmative covenants as well as customary covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, sell certain assets, guarantee obligations of third parties, declare dividends or make certain distributions, and undergo a merger or consolidation or certain other transactions. The Credit Agreement also contains certain financial condition covenants, including maintaining a total level of liquidity of not less than $250.0 million and maintaining a minimum total four-quarter revenue level of $3.0 billion (which are replaced with a covenant to maintain a minimum debt to adjusted EBITDA ratio upon the Company’s meeting a specified adjusted EBITDA threshold). As of December 31, 2021, the Company was in compliance with the covenants under the Credit Agreement. At December 31, 2021, the Company was contingently liable for approximately $4.8 million in standby letters of credit as security for an operating lease obligation. In addition, the Company is required to pledge or otherwise restrict a portion of cash and cash equivalents as collateral for standby letters of credit. As of December 31, 2021, the Company had $86.8 million in letters of credit, which are classified as Restricted cash on its condensed consolidated balance sheets. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The Company is subject to minimum guarantee royalty payments associated under certain music license agreements. The following represents the Company's minimum annual guarantee payments under music license agreements for the next three years as of December 31, 2021 : Future Minimum Payments Fiscal Year (in millions) 2022 (remaining) $ 8.6 2023 32.5 2024 24.6 2025 6.0 Total $ 71.8 Content Costs for Past Use Reserve To secure the rights to stream music on the Peloton platform, the Company must obtain licenses from, and pay royalties to, copyright owners of both sound recordings and musical compositions. The licensors have the right to audit our royalty calculations and routinely exercise those rights. The Company has entered into negotiations with various music rights holders, to pay for any and all uses of musical compositions and sound recordings to date and, at the same time, enter into go-forward license agreements for the use of music in the future. Prior to the execution of go-forward music license agreements, the Company es timates and records expenses inclusive of estimated content costs for past use as well as normal and recurring music royalty expenses. The Company includes both of these components in its reserve. As of December 31, 2021 and 2020, the Company had previously recorded reserves of $10.2 million and $17.6 million , respectively, included in Accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets. Product Recall Reserves On May 5, 2021, the Company announced separate, voluntary recalls of its Tread+ and Tread products in collaboration with the U.S. Consumer Product Safety Commission (" CPSC") and halted sales of these products to work on product enhancements. As a result of these recalls, the Company accrued for a reduction to Connected Fitness Products revenue for actual and estimated future returns of $7.4 million and $18.9 million for the three and six months ended December 31, 2021 , respectively, and a return reserve of $26.7 million is included within Accounts payable and accrued expenses in the accompanying condensed consolidated balance sheets related to the impacts of the recall. The estimated returns reserve is primarily based on historical and expected product returns. The Company recorded costs associated with inventory write-downs and logistic costs of $5.2 million and $5.7 million in Connected Fitness Products cost of revenue for the three and six months ended, December 31, 2021, respectively. Commitments to Suppliers We utilize contract manufacturers to build parts of our products. These contract manufacturers acquire components and build products based on demand forecast information we supply, which typically covers a rolling 12-month period. Consistent with industry practice, we acquire inventories from such manufacturers through blanket purchase orders against which orders are applied based on projected demand information and availability of goods. Such purchase commitments typically cover our forecasted product and manufacturing requirements for periods ranging from 30 to 90 days. In certain instances, these agreements allow us the option to cancel, reschedule and/or adjust our requirements based on our business needs. While our purchase orders are legally cancellable in most situations, there are some which are not cancellable in the event of a demand plan change or other specific circumstances, such as the procurement of unique, Peloton-specific designs, and/or specific non-cancellable, non-returnable components by our suppliers based on our provided forecasts. As the Company materially reduced its demand plan, we are assessing whether to agree to acquire certain inventory purchased by our suppliers under the original demand plan schedule, where appropriate, in an effort to maintain long-term supply continuity, flexibility, scalability perspective with our supply partners. As of December 31, 2021, our commitments to contract with third-party manufacturers for their inventory on-hand and component purchase commitments related to the manufacture of our products were estimated to be approximately $550 million. Legal and Regulatory Proceedings The Company is, or may become, a party to legal and regulatory proceedings with respect to a variety of matters in the ordinary course of business. For example, we received reports of a number of injuries associated with our Tread+ product, one of which led to the death of a child. As a result of those reported Tread+ incidents, in April 2021, the CPSC unilaterally issued a warning to consumers about the safety hazards associated with the Tread+ and is continuing to investigate the matter. In addition to the CPSC investigation and other regulatory investigations, we are presently subject to class action litigation and private personal injury claims related to these perceived defects in the Tread+ and incidents reported to result from its use. Additionally on April 29, 2021, Ashley Wilson filed a putative securities class action lawsuit against the Company and certain of its officers, captioned Wilson v. Peloton Interactive, Inc., et al., Case No. 1:21-cv-02369-CBA-PK, in the United States District Court for the Eastern District of New York, purportedly on behalf of a class consisting of those individuals who purchased or otherwise acquired our common stock between September 11, 2020 and April 16, 2021 (the "Wilson Action"). Plaintiff Wilson amended her lawsuit on May 6, 2021 to expand the purported class to those who purchased or acquired our common stock between September 11, 2020 and May 5, 2021. On May 24, 2021, Leigh Drori filed a related putative securities class action lawsuit, captioned Drori v. Peloton Interactive, Inc., et al., Case No. 1:21-cv-02925-CBA-PK, also in the United States District Court for the Eastern District of New York (the “Drori Action”). On November 16, 2021, the district judge consolidated the Wilson and Drori Actions under the caption In re Peloton Interactive, Inc. Securities Litigation , Master File No. 21-cv-02369-CBA-PK, and appointed Richard Neswick as lead plaintiff. On January 21, 2022, lead plaintiff filed an amended consolidated complaint in the action purportedly on behalf of a class consisting of those individuals who purchased or otherwise acquired our common stock between September 11, 2020 and May 5, 2021. Lead plaintiff alleges that the Company and certain of its officers made false or misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act of 1934 (“Exchange Act”) regarding the Company’s Tread and Tread+ products and the safety of those products. Defendants’ motion to dismiss the amended consolidated complaint is due March 7, 2022. On May 20, 2021, Alan Chu filed a verified shareholder derivative action lawsuit purportedly on behalf of the Company against certain of the Company’s executive officers and the members of the board of directors, captioned Chu v. Foley, et al., Case No. 1:21-cv-02862, in the United States District Court for the Eastern District of New York (the “Chu Action”). Plaintiff Chu alleges breaches of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, waste, and violations of Section 14(a) of the Securities and Exchange Act of 1934, as well as a claim for contribution under Sections 10(b) and 21D of the Securities Exchange Act of 1934 against the Company’s Chief Executive Officer and Chief Financial Officer. On August 13, 2021 and August 19, 2021, two related verified shareholder derivative complaints were filed, captioned Genack v. Foley, et al., Case No. 1:21-cv-04583 and Liu v. Foley, et al., Case No. 1:21-cv-04687, also purportedly on behalf of the Company, in the United States District Court for the Eastern District of New York. On October 13, 2021, the parties in the three putative derivative actions filed a stipulation seeking to consolidate the actions, and agreeing to a schedule for plaintiffs to file motions to be appointed lead plaintiff. On October 26, 2021, the court entered the stipulation consolidating the three actions under the caption In re Peloton Interactive, Inc. Derivative Litigation , Master File No. 21-cv-02862-CBA-PK. On November 23, 2021, Anthony Franchi filed a shareholder derivative action in the United States District Court for the Eastern District of New York against certain of the Company’s executive officers and members of the board of directors captioned Franchi v. Blachford, et al. , Case No. CV 21-06544 (the “Franchi Action”), which alleges breaches of fiduciary duty, unjust enrichment, and violations of Sections 14(a) and 20(a) of the Exchange Act. On January 24, 2022, the court entered a stipulation consolidating the Franchi Action into In re Peloton Interactive, Inc. Derivative Litigation and appointed each plaintiff a co-lead plaintiff. On February 3, 2022, the parties filed a stipulation to stay the consolidated derivative action, which the Court has not yet entered. On November 18, 2021, the City of Hialeah Employees’ Retirement System filed a putative securities class action lawsuit against the Company and certain of its officers in the United States District Court for the Southern District of New York, purportedly on behalf of a class consisting of those individuals who purchased or otherwise acquired our common stock between December 9, 2020 and November 4, 2021, captioned City of Hialeah Employees’ Retirement System v. Peloton Interactive, Inc. , Case No. 21-cv-09582-ALC (the “Hialeah Action”). On December 2, 2021, Anastasia Deulina filed a related putative securities class action against the same defendants also in the United States District Court for the Southern District of New York captioned Deulina v. Peloton Interactive, Inc. , Case No. 21-cv-10266-ALC (the “Deulina Action”). The Hialeah and Deulina Actions allege that Defendants made false and misleading statements in violation of Sections 10(b) and 20(a) of the Exchange Act regarding demand for, and supply of, the Company’s products. On January 18, 2022, several purported shareholders filed motions to consolidate the Hialeah and Deulina Actions and to be appointed lead plaintiff. The Court has not yet ruled on those motions. After the Court appoints a lead plaintiff and lead counsel, the parties will negotiate and submit a proposed schedule for lead plaintiff to file a consolidated amended complaint and for defendants to file a motion to dismiss. In April 2021, DISH Technologies L.L.C., and Sling TV L.L.C. (DISH) filed a complaint in the United States District Court for the Eastern District of Texas. DISH, along with DISH DBS Corporation, also filed a complaint in the United States International Trade Commission (ITC) under Section 337 of the Tariff Act of 1930 against the Company, along with ICON Health & Fitness, Inc. (now iFIT Inc. f/k/a Icon Health & Fitness, Inc.), FreeMotion Fitness, Inc., NordicTrack, Inc., lululemon athletica, inc., and Curiouser Products Inc. d/b/a MIRROR. The complaints allege infringement of various patents related to fitness devices containing internet-streaming enabled video displays. In the ITC complaint, DISH seeks an exclusion order barring the importation of Peloton Connected Fitness devices, and streaming components and systems containing components thereof that infringe one or more of the asserted patents, as well as a cease and desist order preventing the Company from carrying out commercial activities within the United States related to those products. In the Eastern District of Texas complaint, DISH is seeking an order permanently enjoining the Company from infringing the asserted patents, an award of damages for the infringement of the asserted patents, and an award of damages for lost sales. The ITC investigation is ongoing and the Texas litigation remains stayed pending resolution to the ITC investigation. On February 2, 2022, iFit Inc. (“iFit”) filed a complaint with the United States International Trade Commission (ITC) under Section 337 of the Tariff Act of 1930 against the Company, along with Peloton Interactive, UK Ltd., Tonic Fitness Technology, Inc., and Rexon Industrial Corp., Ltd., alleging infringement of a continuation of a patent that is already at issue in a separate litigation between the Company and iFit, iFit Inc. v. Peloton Interactive Inc., C.A. No. 21-cv-0507-RGA (D. Del)., and that is related to an exercise system that includes a stationary bicycle having pedals, a free weight cradle, as well as a display with one or more processors and memory and programmed workouts. iFit seeks an exclusion order barring the importation of the Peloton exercise system and components that infringe the asserted patent, as well as a cease and desist order preventing the Company from carrying out certain commercial activities within the United States related to such imported products. |
Equity-Based Compensation
Equity-Based Compensation | 6 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Equity-Based Compensation | Equity-Based Compensation 2019 Equity Incentive Plan In August 2019, the Board of Directors adopted the 2019 Equity Incentive Plan (the "2019 Plan"), which was subsequently approved by the Company’s stockholders in September 2019. The 2019 Plan serves as the successor to the 2015 Stock Plan (the "2015 Plan"). The 2015 Plan continues to govern the terms and conditions of the outstanding awards previously granted thereunder. Any reserved shares not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2019 Plan became available for grant under the 2019 Plan and will be issued as Class A common stock. The number of shares reserved for issuance under the 2019 Plan will increase automatically on July 1 of each of 2020 through 2029 by the number of shares of the Company’s Class A common stock equal to 5% of the total outstanding shares of all of the Company’s classes of common stock as of each June 30 immediately preceding the date of increase, or a lesser amount as determined by the Board of Directors. On July 1, 2021, the number of shares of Class A common stock available for issuance under the 2019 Plan was automatically increased according to its terms by 15,007,356 shares. As of December 31, 2021, 59,172,230 shares of Class A common stock are available for future award under the 2019 Plan. Stock Options The following summary sets forth the stock option activity under the 2019 Plan: Options Outstanding Number of Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in millions) Outstanding — June 30, 2021 57,946,608 $ 18.47 7.3 $ 6,119.2 Granted 3,522,970 $ 96.07 Exercised (3,157,764) $ 9.44 $ 241.1 Forfeited (684,266) $ 58.32 Outstanding — December 31, 2021 57,627,548 $ 23.23 7.0 $ 1,226.5 Vested and Exercisable— December 31, 2021 33,141,759 $ 11.10 6.2 $ 891.2 Unvested option activity is as follows: Options Weighted-Average Grant Date Fair Value Unvested - June 30, 2021 28,160,034 $ 13.52 Granted 3,522,970 $ 43.15 Early exercised unvested (13,501) $ 2.02 Vested (6,511,747) $ 10.95 Forfeited or expired (671,967) $ 25.87 Unvested - December 31, 2021 24,485,789 $ 18.13 The aggregate intrinsic value of options outstanding and vested and exercisable, were calculated as the difference between the exercise price of the options and the fair value of the Company’s common stock as of December 31, 2021. The fair value of the common stock is the closing stock price of the Company's Class A common stock as reported on the Nasdaq Global Select Market. The aggregate intrinsic value of exercised options was $241.1 million and $523.4 million for the six months ended December 31, 2021 and 2020, respectively. For the six months ended December 31, 2021 and 2020, the weighted-average grant date fair value per option was $43.15 and $36.05, respectively. The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: Six Months Ended December 31, 2021 Weighted average risk-free interest rate (1) 1.0% Weighted average expected term (in years) 6.0 Weighted average expected volatility (2) 47.0% Expected dividend yield — ____________________________ (1) Based on U.S. Treasury yield curve in effect at the time of grant. (2) Expected volatility is based on a blended average of average historical stock volatilities of several peer companies over the expected term of the stock options, historical volatility of the Company's stock price, and implied stock price volatility derived from the price of exchange traded options on the Company's stock. Restricted Stock and Restricted Stock Units The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Restricted Stock Units Outstanding Number of Awards Weighted-Average Grant Date Fair Value Outstanding — June 30, 2021 1,785,946 $ 99.43 Granted 2,667,778 $ 96.09 Vested and converted to shares (669,555) $ 99.46 Cancelled (127,989) $ 105.80 Outstanding — December 31, 2021 3,656,180 $ 96.77 Employee Stock Purchase Plan In August 2019, the Board of Directors adopted, and in September 2019, the Company's stockholders approved, the 2019 Employee Stock Purchase Plan ("ESPP"), through which eligible employees may purchase shares of the Company's Class A common stock at a discount through accumulated payroll deductions. The ESPP became effective on the date the registration statement, in connection with the Company’s IPO, was declared effective by the SEC (the "Effective Date"). The number of shares of the Company's Class A common stock that will be available for issuance and sale to eligible employees under the ESPP will increase automatically on the first day of each fiscal year of the Company beginning on July 1, 2020 through 2029, equal to 1% of the total number of outstanding shares of all classes of the Company's common stock on the immediately preceding June 30, or such lesser number as may be determined by the Board of Directors or applicable committee in its sole discretion. On July 1, 2021, the number of shares of Class A common stock available for issuance under the ESPP was automatically increased according to its terms by 3,001,471 shares. As of December 31, 2021, a total of 10,568,799 shares of Class A common stock were available for sale to employees under the ESPP. Unless otherwise determined by the Board of Directors, each offering period will consist of four six-month purchase periods, provided that the initial offering period commenced on the Effective Date and ended on August 31, 2021, and the initial purchase period ended February 28, 2020. Thereafter, each offering period and each purchase period will commence on September 1 and March 1 and end on August 31 and February 28 of each two-year period or each six-month period, respectively, subject to a reset provision. If the closing stock price on the first day of an offering period is higher than the closing stock price on the last day of any applicable purchase period, participants will be withdrawn from the ongoing offering period immediately following the purchase of ESPP shares on the purchase date and would automatically be enrolled in the subsequent offering period, resulting in a modification under ASC 718. Unless otherwise determined by the Board of Directors, the purchase price for each share of Class A common stock purchased under the ESPP will be 85% of the lower of the fair market value per share on the first trading day of the applicable offering period or the fair market value per share on the last trading day of the applicable purchase period. There was an ESPP reset in the six months ended December 31, 2021 that resulted in a total modification charge of $3.5 million, which is recognized over the new two-year offering period ending August 31, 2023. The Black-Scholes option pricing model assumptions used to calculate the fair value of shares estimated to be purchased at the commencement of the ESPP offering periods were as follows: Six Months Ended December 31, 2021 Weighted average risk-free interest rate 0.5% Weighted average expected term (in years) 1.2 Weighted average expected volatility 64.9% Expected dividend yield — The expected term assumptions were based on each offering period's respective purchase date. The expected volatility was derived from the blended average of historical stock volatilities of several unrelated public companies that the Company considers to be comparable to its business over a period equivalent to the expected terms of the stock options and the historical volatility of the Company's stock price. The risk-free rate assumptions were based on the U.S. treasury yield curve in effect at the time of the grants. The dividend yield assumption was zero as the Company has not historically paid any dividends and does not expect to declare or pay dividends in the foreseeable future. During the three and six months ended December 31, 2021, the Company recorded stock-based compensation expense associated with the ESPP of $4.6 million and $8.2 million, respectively, and $2.2 million and $3.8 million for the three and six months ended December 31, 2020, respectively. In connection with the offering period which ended on August 31, 2021, employees purchased 293,356 shares of Class A common stock at a weighted-average price of $39.95 under the ESPP. As of December 31, 2021, total unrecognized compensation cost related to the ESPP was $21.6 million, which will be amortized over a weighted-average remaining period of 1.5 years. Stock-Based Compensation Expense The Company's total stock-based compensation expense was as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Cost of revenue Connected Fitness Products $ 6.6 $ 2.0 $ 11.0 $ 3.5 Subscription 5.1 5.1 8.7 9.5 Total cost of revenue 11.7 7.1 19.7 13.0 Sales and marketing 9.0 4.6 15.5 8.0 General and administrative 38.3 21.2 67.8 37.8 Research and development 12.9 4.6 21.7 8.2 Total stock-based compensation expense $ 71.9 $ 37.5 $ 124.8 $ 67.1 As of December 31, 2021, the Company had $738.1 million of unrecognized stock-based compensation expense related to unvested stock-based awards that is expected to be recognized over a weighted-average period of 3.0 years. |
Income Taxes
Income Taxes | 6 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company recorded a provision from income taxes of $3.1 million and $5.4 million for the three and six months ended December 31, 2021, respectively, and a benefit of $3.0 million and $1.7 million for the three and six months ended December 31, 2020, respectively. Furthermore, the Company's effective tax rates were (0.71)% and (0.67)% for the three and six months ended December 31, 2021, respectively, and (4.60)% and (1.24)% for the three and six months ended December 31, 2020, respectively. The income tax provision and the effective tax rate is primarily driven by state and international taxes. The Company maintains a valuation allowance on the majority of its deferred tax assets as it has concluded that it is more likely than not that the deferred assets will not be utilized. |
Net (Loss) Income Per Share
Net (Loss) Income Per Share | 6 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net (Loss) Income Per Share | Net (Loss) Income Per Share The computation of basic and diluted net (loss) income per share is as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions, except share and per share amounts) Basic net (loss) income per share: Net (loss) income attributable to common stockholders $ (439.4) $ 63.6 $ (815.3) $ 132.8 Shares used in computation: Weighted-average common shares outstanding 317,110,297 292,462,184 309,119,648 290,591,037 Basic net (loss) income per share $ (1.39) $ 0.22 $ (2.64) $ 0.46 Diluted net (loss) income per share: Net (loss) income attributable to common stockholders $ (439.4) $ 63.6 $ (815.3) $ 132.8 Shares used in computation: Weighted-average common shares outstanding 317,110,297 292,462,184 309,119,648 290,591,037 Weighted-average effect of potentially dilutive securities: Employee stock options — 54,271,831 — 53,426,104 Restricted stock units and awards — 636,056 — 552,394 Shares estimated to be purchased under ESPP — 516,624 — 424,779 Diluted weighted-average common shares outstanding 317,110,297 347,886,695 309,119,648 344,994,314 Diluted net (loss) income per share $ (1.39) $ 0.18 $ (2.64) $ 0.39 The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 Employee stock options 44,011,349 65,236 47,438,668 206,467 Restricted stock units and awards 104,006 590 252,433 6,761 Shares estimated to be purchased under ESPP — — 56,740 — The Company expects to settle the principal amount of the Notes in cash upon conversion, and therefore, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion option on diluted net income per share, if applicable. The conversion option will have a dilutive impact on net loss per share of common stock when the average market price per share of the Company's Class A common stock for a given period exceeds the conversion price of the Notes of $239.23 per share. During the three and six months ended December 31, 2021, the weighted average price per share of the Company's Class A common stock was below the conversion price of the Notes. The denominator for basic and diluted (loss) income per share does not include any effect from the Capped Call Transactions the Company entered into concurrently with the issuance of the Notes as this effect would be anti-dilutive. In the event of conversion of the Notes, if shares are delivered to the Company under the Capped Call Transactions, they will offset the dilutive effect of the shares that the Company would issue under the Notes. |
Segment Information
Segment Information | 6 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information The Company applies ASC 280, Segment Reporting , in determining reportable segments. The Company has two reportable segments: Connected Fitness Products and Subscription. Segment information is presented in the same manner that the chief operating decision maker ("CODM") reviews the operating results in assessing performance and allocating resources. The CODM reviews revenue and gross profit for both of the reportable segments. Gross profit is defined as revenue less cost of revenue incurred by the segment. No operating segments have been aggregated to form the reportable segments. The Company does not allocate assets at the reportable segment level as these are managed on an entity wide group basis and, accordingly, the Company does not report asset information by segment. The Connected Fitness Product segment derives revenue from sale of the Company's portfolio of Connected Fitness Products and related accessories, delivery and installation services, branded apparel, and extended warranty agreements. The Subscription segment derives revenue from monthly Subscription fees. There are no internal revenue transactions between the Company’s segments. Key financial performance measures of the segments including Revenue, Cost of revenue, and Gross profit are as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Connected Fitness Products: Revenue $ 796.4 $ 870.1 $ 1,297.4 $ 1,471.5 Cost of revenue 745.5 562.8 1,186.2 927.0 Gross profit $ 51.0 $ 307.3 $ 111.3 $ 544.5 Subscription: Revenue $ 337.5 $ 194.7 $ 641.7 $ 351.2 Cost of revenue 108.3 77.2 210.0 142.2 Gross profit $ 229.3 $ 117.5 $ 431.7 $ 209.0 Consolidated: Revenue $ 1,133.9 $ 1,064.8 $ 1,939.1 $ 1,822.7 Cost of revenue 853.7 640.0 1,396.2 1,069.2 Gross profit $ 280.2 $ 424.8 $ 543.0 $ 753.5 Reconciliation of Gross Profit Operating expenditures, interest income and other expense, and taxes are not allocated to individual segments as these are managed on an entity wide group basis. The reconciliation between reportable Segment Gross Profit to consolidated (loss) income before tax is as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Segment Gross Profit $ 280.2 $ 424.8 $ 543.0 $ 753.5 Sales and marketing (349.6) (177.4) (633.9) (292.1) General and administrative (248.7) (141.1) (489.0) (249.7) Research and development (100.0) (47.5) (197.7) (84.1) Impairment expense (7.7) — (7.7) — Total other (expense) income, net (10.6) 1.8 (24.6) 3.5 (Loss) income before provision for income taxes $ (436.3) $ 60.6 $ (809.9) $ 131.2 |
Stockholders' Equity
Stockholders' Equity | 6 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders' Equity On November 16, 2021, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC as representatives of the several underwriters named therein (collectively, the “Representatives”) relating to the offer and sale by the Company (the “Offering”) of 27,173,912 shares (the “Shares”) of the Company’s Class A common stock, par value $0.000025 per share, which includes 3,260,869 shares of Class A common stock issued and sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares of Class A common stock pursuant to the Underwriting Agreement. The Company sold the Shares to the underwriters at the public offering price of $46.00 per share less underwriting discounts . The net proceeds to the Company from the Offering were approximately $1.2 billion after deducting the underwriters’ discounts and commissions. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events February 2022 Restructuring Plan On February 1, 2022, following the Company’s previous disclosure regarding market factors impacting the business, the Company’s Board of Directors approved a restructuring plan to realign the Company’s operational focus to support its multi-year growth, scale the business, and improve costs (the “Restructuring Plan”). The Restructuring Plan includes: (i) reducing the Company’s headcount; (ii) closing several assembly and manufacturing plants, including the completion and subsequent sale of the shell facility for the Company’s previously planned Peloton Output Park; (iii) closing and consolidating several distribution facilities, and (iv) shifting to third-party logistics providers in certain locations. The Company expects the Restructuring Plan to be substantially implemented by the end of fiscal 2024. In connection with the Restructuring Plan, the Company estimates that it will incur total cash charges of approximately $190 million composed of: (i) approximately $90 million for severance and other related personnel reduction costs; (ii) approximately $40 million related to closing and consolidating several assembly and manufacturing plants and distribution facilities; and (iii) approximately $60 million in capital expenditures. Additionally, the Company expects to recognize approximately $80 million of asset impairment charges in the third fiscal quarter of 2022 in connection with the Restructuring Plan. The Company expects to achieve at least $800 million in annualized run-rate cost savings as a result of the Restructuring Plan, with the majority expected to be realized by the end of fiscal 2024. CEO Transition On February 7, 2022, the Board appointed Barry McCarthy as the Chief Executive Officer and President of the Company to succeed John Foley, the Company’s Co-Founder and former Chief Executive Officer, in this role, and appointed Mr. Foley as Executive Chair of the Board, in each case, as of February 9, 2022 (the “CEO Commencement Date”). Additionally, Mr. McCarthy has been designated as the Company’s principal executive officer, effective as of the CEO Commencement Date. The Company and Mr. McCarthy have entered into an employment offer letter, dated February 7, 2022, in connection with Mr. McCarthy’s appointment as Chief Executive Officer (the “Offer Letter”). As part of the Offer Letter, Mr. McCarthy was granted a stock option award to purchase 8,000,000 shares of the Company’s Class A Common Stock (the “Option Award”). The Option Award will have an exercise price per share equal to the closing price of the Company’s Class A common stock on the CEO Commencement Date and will vest and become exercisable over four years. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 6 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | The accompanying interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting.Certain monetary amounts, percentages, and other figures included elsewhere in these financial statements have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables may not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the percentages that precede them. |
Consolidation | The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates | The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, the realizability of inventory, content costs for past use reserve, fair value measurements, the incremental borrowing rate associated with lease liabilities, impairment of long-lived and intangible assets, useful lives of long lived assets, including property and equipment and finite lived intangible assets, product warranty, goodwill, accounting for income taxes, stock-based compensation expense, transaction price estimates, the fair values of assets acquired and liabilities assumed in business combinations and asset acquisitions, valuation of the debt component of convertible senior notes, contingent consideration, and commitments and contingencies. Actual results may differ from these estimates. |
Derivative Instruments and Hedging Activities | Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of foreign currency exchange risk. As required by ASC 815, the Company records all derivatives on the balance sheet at fair value in the following line items: Prepaid expenses and other current assets; and Other current liabilities. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. The Company does not currently have fair value or net investment hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. In addition to our derivatives where we apply hedge accounting, the Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. The Company evaluates its convertible instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives requiring separate recognition in the Company’s financial statements in accordance with the criteria under ASC 815-15. As of December 31, 2021, the Company did not have any material derivative contracts or contracts with material embedded derivative features requiring bifurcation. |
Recently Issued Accounting Pronouncements | Accounting Pronouncements Recently Adopted ASU 2020-01 In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions between Topic 321, Topic 323, and Topic 815. This guidance clarifies the interaction of the accounting for equity investments under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. This standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company has completed its assessment and adopted this standard on July 1, 2021. The adoption of this standard did not materially impact the Company’s condensed consolidated financial statements. ASU 2020-04 and ASU 2021-01 In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . This guidance provides temporary optional expedients and exceptions to accounting guidance on contract modifications and hedge accounting to ease entities’ financial reporting burdens as the market transitions from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848) , which refines the scope of Topic ASC 848 and clarifies some of its guidance. The amendments in ASU 2021-01 are elective and apply to all entities that have derivative instruments that use an interest rate for margining, discounting, or contract price alignment that is modified as a result of reference rate reform. The guidance in both updates was effective upon issuance and generally can be applied through December 31, 2022. The Company adopted this standard after LIBOR was discontinued on December 31, 2021. The adoption of this standard did not materially impact the Company's condensed consolidated financial statements. Accounting Pronouncements Not Yet Adopted ASU 2020-06 In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging- Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity . The guidance will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock, thereby limiting the accounting results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. In addition, the guidance eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if-converted method. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. Upon adoption, the Company expects a decrease to Additional paid-in capital to remove the equity component separately recorded for the conversion features associated with the Notes (as defined in Note 7 - Debt of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q), an increase in the carrying value of its Notes to reflect the full principal amount of the Notes outstanding net of issuance costs, and an increase to Accumulated deficit. The Company expects the adoption of this standard to reduce its reported Interest expense. ASU 2021-08 In October 2021, the Financial Accounting Standards Board issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The guidance requires that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers . This standard is effective for annual periods beginning after December 15, 2022, including interim periods therein, with early adoption permitted, and should be applied prospectively to acquisitions occurring on or after the effective date. The Company will continue to evaluate the impact of this guidance, which will depend on the contract assets and liabilities acquired in future business combinations. |
Revenue Recognition | The Company’s primary source of revenue is from sales of its Connected Fitness Products and associated recurring Subscription revenues. The Company determines revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue is recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s revenue is reported net of sales returns, discounts, incentives, and rebates to commercial distributors as a reduction of the transaction price. Certain contracts include consideration payable that is accounted for as a payment for distinct goods or services. The Company estimates its liability for product returns and concessions based on historical trends by product category, impact of seasonality, and an evaluation of current economic and market conditions and records the expected customer refund liability as a reduction to revenue, and the expected inventory right of recovery as a reduction of cost of revenue. If actual return costs differ from previous estimates, the amount of the liability and corresponding revenue are adjusted in the period in which such costs occur. Some of the Company’s contracts with customers contain multiple performance obligations. For customer contracts that include multiple performance obligations, the Company accounts for individual performance obligations if they are distinct. The transaction price is then allocated to each performance obligation based on its standalone selling price. The Company generally determines the standalone selling price based on the prices charged to customers. The Company applies the practical expedient as per ASC 606-10-50-14 and does not disclose information related to remaining performance obligations due to their original expected terms being one year or less. The Company expenses sales commissions on its Connected Fitness Products when incurred because the amortization period would have been less than one year. These costs are recorded in Sales and marketing in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Connected Fitness Products Connected Fitness Products include the Company’s portfolio of Connected Fitness Products and related accessories, Precor branded fitness products, delivery and installation services, Peloton branded apparel, extended warranty agreements, and commercial service contracts. The Company recognizes Connected Fitness Product revenue net of sales returns and discounts when the product has been delivered to the customer, except for extended warranty revenue which is recognized over the warranty period and service revenue which is recognized over the term of the service contract. The Company allows customers to return Peloton branded Connected Fitness Products within thirty days of purchase, as stated in its return policy. The Company records fees paid to third-party financing partners in connection with its consumer financing program as a reduction of revenue, as it considers such costs to be a customer sales incentive. The Company records payment processing fees for its credit card sales for Connected Fitness Products within Sales and marketing in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Subscription The Company’s subscriptions provide unlimited access to content in its library of live and on-demand fitness classes. The Company’s subscriptions are offered on a month-to-month basis. Amounts paid for subscription fees, net of refunds are included within Customer deposits and deferred revenue on the Company’s condensed consolidated balance sheets and recognized ratably over the subscription term. The Company records payment processing fees for its monthly subscription charges within cost of Subscription revenue in the Company’s condensed consolidated statements of operations and comprehensive (loss) income. Sales tax collected from customers and remitted to governmental authorities is not included in revenue and is reflected as a liability on the Company’s condensed consolidated balance sheets. |
Customer Deposits and Deferred Revenue | Deferred revenue is recorded for nonrefundable cash payments received for the Company’s performance obligation to transfer, or stand ready to transfer, goods or services in the future. Customer deposits represent payments received in advance before the Company transfers a good or service to the customer and are refundable. |
Fair Value Measurements | The fair value of the 0% Convertible Senior Notes due February 15, 2026 (the “Notes”) is determined based on the closing price on the last trading day of the reporting period. |
Revenue (Tables)
Revenue (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Product Warranty Liability | Activity related to the Company’s accrual for our estimated future product warranty obligation was as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Balance at beginning of period $ 44.4 $ 38.6 $ 51.5 $ 34.2 Provision for warranty accrual 18.8 6.8 26.1 17.5 Warranty claims (14.7) (12.8) (29.1) (19.1) Balance at end of period $ 48.5 $ 32.6 $ 48.5 $ 32.6 |
Schedule of Disaggregation of Revenue | The Company’s revenue disaggregated by geographic region, were as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) North America $ 1,035.0 $ 1,007.8 $ 1,763.8 $ 1,729.7 International 98.9 57.0 175.3 93.0 Total revenue $ 1,133.9 $ 1,064.8 $ 1,939.1 $ 1,822.7 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments | The following table presents the estimated fair values of the Company’s financial instruments that are not recorded at fair value on the condensed consolidated balance sheets: As of December 31, 2021 Level 1 Level 2 Level 3 Total (in millions) Convertible Senior Notes $ — $ 852.3 $ — $ 852.3 |
Inventories (Tables)
Inventories (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | Inventories were as follows: December 31, 2021 June 30, 2021 (in millions) Raw materials $ 100.3 $ 109.8 Work-in-process 5.5 7.9 Finished products (1) 1,522.0 879.5 Total inventories 1,627.8 997.2 Less: Reserves (86.5) (60.1) Total inventories, net $ 1,541.3 $ 937.1 _________________________ |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
Convertible Debt | The net carrying amount of the liability component of the Notes was as follows: December 31, 2021 (in millions) Principal $ 1,000.0 Unamortized debt discount (137.1) Unamortized debt issuance costs (16.2) Net carrying amount $ 846.7 The following table sets forth the interest expense recognized related to the Notes: Three Months Ended December 31, 2021 Six Months Ended December 31, 2021 (in millions) Amortization of debt discount $ 7.7 $ 15.3 Amortization of debt issuance costs 0.8 1.6 Less: Interest capitalized (0.2) (0.2) Total interest expense related to the Notes $ 8.3 $ 16.7 |
Commitment and Contingencies (T
Commitment and Contingencies (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule Of Minimum Guarantee Royalty Payments Due Under Music License Agreements | The following represents the Company's minimum annual guarantee payments under music license agreements for the next three years as of December 31, 2021 : Future Minimum Payments Fiscal Year (in millions) 2022 (remaining) $ 8.6 2023 32.5 2024 24.6 2025 6.0 Total $ 71.8 |
Equity-Based Compensation (Tabl
Equity-Based Compensation (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Stock Option Activity | The following summary sets forth the stock option activity under the 2019 Plan: Options Outstanding Number of Stock Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in millions) Outstanding — June 30, 2021 57,946,608 $ 18.47 7.3 $ 6,119.2 Granted 3,522,970 $ 96.07 Exercised (3,157,764) $ 9.44 $ 241.1 Forfeited (684,266) $ 58.32 Outstanding — December 31, 2021 57,627,548 $ 23.23 7.0 $ 1,226.5 Vested and Exercisable— December 31, 2021 33,141,759 $ 11.10 6.2 $ 891.2 Unvested option activity is as follows: Options Weighted-Average Grant Date Fair Value Unvested - June 30, 2021 28,160,034 $ 13.52 Granted 3,522,970 $ 43.15 Early exercised unvested (13,501) $ 2.02 Vested (6,511,747) $ 10.95 Forfeited or expired (671,967) $ 25.87 Unvested - December 31, 2021 24,485,789 $ 18.13 |
Schedule of Fair Value Assumptions | The fair value of each option was estimated at the grant date using the Black-Scholes method with the following assumptions: Six Months Ended December 31, 2021 Weighted average risk-free interest rate (1) 1.0% Weighted average expected term (in years) 6.0 Weighted average expected volatility (2) 47.0% Expected dividend yield — ____________________________ (1) Based on U.S. Treasury yield curve in effect at the time of grant. (2) Expected volatility is based on a blended average of average historical stock volatilities of several peer companies over the expected term of the stock options, historical volatility of the Company's stock price, and implied stock price volatility derived from the price of exchange traded options on the Company's stock. |
Schedule of Restricted Stock and Restricted Stock Units | The following table summarizes the activity related to the Company's restricted stock and restricted stock units: Restricted Stock Units Outstanding Number of Awards Weighted-Average Grant Date Fair Value Outstanding — June 30, 2021 1,785,946 $ 99.43 Granted 2,667,778 $ 96.09 Vested and converted to shares (669,555) $ 99.46 Cancelled (127,989) $ 105.80 Outstanding — December 31, 2021 3,656,180 $ 96.77 |
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions | The Black-Scholes option pricing model assumptions used to calculate the fair value of shares estimated to be purchased at the commencement of the ESPP offering periods were as follows: Six Months Ended December 31, 2021 Weighted average risk-free interest rate 0.5% Weighted average expected term (in years) 1.2 Weighted average expected volatility 64.9% Expected dividend yield — |
Schedule of Stock-Based Compensation Expense | The Company's total stock-based compensation expense was as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Cost of revenue Connected Fitness Products $ 6.6 $ 2.0 $ 11.0 $ 3.5 Subscription 5.1 5.1 8.7 9.5 Total cost of revenue 11.7 7.1 19.7 13.0 Sales and marketing 9.0 4.6 15.5 8.0 General and administrative 38.3 21.2 67.8 37.8 Research and development 12.9 4.6 21.7 8.2 Total stock-based compensation expense $ 71.9 $ 37.5 $ 124.8 $ 67.1 |
Net (Loss) Income Per Share (Ta
Net (Loss) Income Per Share (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Computation of Basic and Diluted net (Loss) Income Per Share | The computation of basic and diluted net (loss) income per share is as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions, except share and per share amounts) Basic net (loss) income per share: Net (loss) income attributable to common stockholders $ (439.4) $ 63.6 $ (815.3) $ 132.8 Shares used in computation: Weighted-average common shares outstanding 317,110,297 292,462,184 309,119,648 290,591,037 Basic net (loss) income per share $ (1.39) $ 0.22 $ (2.64) $ 0.46 Diluted net (loss) income per share: Net (loss) income attributable to common stockholders $ (439.4) $ 63.6 $ (815.3) $ 132.8 Shares used in computation: Weighted-average common shares outstanding 317,110,297 292,462,184 309,119,648 290,591,037 Weighted-average effect of potentially dilutive securities: Employee stock options — 54,271,831 — 53,426,104 Restricted stock units and awards — 636,056 — 552,394 Shares estimated to be purchased under ESPP — 516,624 — 424,779 Diluted weighted-average common shares outstanding 317,110,297 347,886,695 309,119,648 344,994,314 Diluted net (loss) income per share $ (1.39) $ 0.18 $ (2.64) $ 0.39 |
Schedule of Potentially Diluted Securities Not Included in Calculation of Diluted Shares Outstanding | The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 Employee stock options 44,011,349 65,236 47,438,668 206,467 Restricted stock units and awards 104,006 590 252,433 6,761 Shares estimated to be purchased under ESPP — — 56,740 — |
Segment Information (Tables)
Segment Information (Tables) | 6 Months Ended |
Dec. 31, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Key Performance Measures by Segment | Key financial performance measures of the segments including Revenue, Cost of revenue, and Gross profit are as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Connected Fitness Products: Revenue $ 796.4 $ 870.1 $ 1,297.4 $ 1,471.5 Cost of revenue 745.5 562.8 1,186.2 927.0 Gross profit $ 51.0 $ 307.3 $ 111.3 $ 544.5 Subscription: Revenue $ 337.5 $ 194.7 $ 641.7 $ 351.2 Cost of revenue 108.3 77.2 210.0 142.2 Gross profit $ 229.3 $ 117.5 $ 431.7 $ 209.0 Consolidated: Revenue $ 1,133.9 $ 1,064.8 $ 1,939.1 $ 1,822.7 Cost of revenue 853.7 640.0 1,396.2 1,069.2 Gross profit $ 280.2 $ 424.8 $ 543.0 $ 753.5 |
Schedule of Reconciliation of Segment Gross Profit to Consolidated Loss Before Tax | The reconciliation between reportable Segment Gross Profit to consolidated (loss) income before tax is as follows: Three Months Ended December 31, Six Months Ended December 31, 2021 2020 2021 2020 (in millions) Segment Gross Profit $ 280.2 $ 424.8 $ 543.0 $ 753.5 Sales and marketing (349.6) (177.4) (633.9) (292.1) General and administrative (248.7) (141.1) (489.0) (249.7) Research and development (100.0) (47.5) (197.7) (84.1) Impairment expense (7.7) — (7.7) — Total other (expense) income, net (10.6) 1.8 (24.6) 3.5 (Loss) income before provision for income taxes $ (436.3) $ 60.6 $ (809.9) $ 131.2 |
Revenue - Narrative (Details)
Revenue - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2021 | |
Disaggregation of Revenue [Line Items] | |||||
Allowable product return period (in days) | 30 days | ||||
Standard product warranty period (in years) | 1 year | ||||
Revenue | $ 1,133.9 | $ 1,064.8 | $ 1,939.1 | $ 1,822.7 | |
Customer deposits | 159.9 | 159.9 | $ 92.2 | ||
Deferred revenue | 80.6 | 80.6 | $ 72.6 | ||
Revenue recognized that was previously included in deferred revenue | 64.9 | 22.1 | |||
United States | |||||
Disaggregation of Revenue [Line Items] | |||||
Revenue | $ 982.7 | $ 971.4 | $ 1,678.9 | $ 1,673.7 | |
United States | Revenue Benchmark | Geographic Concentration Risk | |||||
Disaggregation of Revenue [Line Items] | |||||
Percentage of total revenue | 87.00% | 91.00% | 87.00% | 92.00% | |
Minimum | |||||
Disaggregation of Revenue [Line Items] | |||||
Extended product warranty period (in months) | 12 months | ||||
Maximum | |||||
Disaggregation of Revenue [Line Items] | |||||
Extended product warranty period (in months) | 27 months |
Revenue - Standard Product Warr
Revenue - Standard Product Warranty (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward] | ||||
Balance at beginning of period | $ 44.4 | $ 38.6 | $ 51.5 | $ 34.2 |
Provision for warranty accrual | 18.8 | 6.8 | 26.1 | 17.5 |
Warranty claims | (14.7) | (12.8) | (29.1) | (19.1) |
Balance at end of period | $ 48.5 | $ 32.6 | $ 48.5 | $ 32.6 |
Revenue - Disaggregation of Rev
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 1,133.9 | $ 1,064.8 | $ 1,939.1 | $ 1,822.7 |
North America | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | 1,035 | 1,007.8 | 1,763.8 | 1,729.7 |
International | ||||
Disaggregation of Revenue [Line Items] | ||||
Total revenue | $ 98.9 | $ 57 | $ 175.3 | $ 93 |
Fair Value Measurements - Other
Fair Value Measurements - Other Financial Instruments (Details) $ in Millions | Dec. 31, 2021USD ($) |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Convertible Senior Notes | $ 852.3 |
Level 1 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Convertible Senior Notes | 0 |
Level 2 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Convertible Senior Notes | 852.3 |
Level 3 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Convertible Senior Notes | $ 0 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) | Feb. 28, 2021 |
0% Convertible Senior Notes Due February 15, 2026 | Convertible Debt | |
Debt Instrument [Line Items] | |
Convertible debt, stated interest rate | 0.00% |
Inventories (Details)
Inventories (Details) - USD ($) $ in Millions | Dec. 31, 2021 | Jun. 30, 2021 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 100.3 | $ 109.8 |
Work-in-process | 5.5 | 7.9 |
Finished products | 1,522 | 879.5 |
Total inventories | 1,627.8 | 997.2 |
Less: Reserves | (86.5) | (60.1) |
Total inventories, net | 1,541.3 | 937.1 |
Other inventory, in transit | $ 572.3 | $ 249.9 |
Acquisitions - Narrative (Detai
Acquisitions - Narrative (Details) $ in Millions | Apr. 01, 2021USD ($)entity | Dec. 31, 2021USD ($)period | Sep. 30, 2021USD ($) | Dec. 31, 2021USD ($)period |
Asset Acquisition 2020 | ||||
Schedule of Business Combination and Asset Acquisition [Line Items] | ||||
Number of asset acquisition agreements | period | 2 | 2 | ||
Goodwill | $ 12 | $ 12 | ||
Asset Acquisition 2020 | Software | ||||
Schedule of Business Combination and Asset Acquisition [Line Items] | ||||
Assets acquired | $ 17.7 | $ 17.7 | ||
Useful life | 3 years | |||
Precor Inc. | ||||
Schedule of Business Combination and Asset Acquisition [Line Items] | ||||
Number of legal entities acquired on business combination | entity | 15 | |||
Purchase price | $ 412 | $ 409.2 | ||
Purchase consideration | $ 2.9 | |||
Inventories | $ (4) | |||
Intangible assets | 1 | |||
Increase (decrease) in deferred tax asset | (3.4) | |||
Increase in goodwill | 3.5 | |||
Fair value assessment | $ 0.1 |
Debt - Convertible Notes and In
Debt - Convertible Notes and Indenture (Details) $ / shares in Units, shares in Millions | 1 Months Ended |
Feb. 28, 2021USD ($)period$ / sharesshares | |
Over-Allotment Option | |
Line of Credit Facility [Line Items] | |
Value of shares available for exercise | $ 125,000,000 |
Convertible Debt | Convertible Notes Maturing February 15, 2026 | |
Line of Credit Facility [Line Items] | |
Principal amount | 1,000,000,000 |
Proceeds from public offering, net of issuance costs | $ 977,200,000 |
Debt instrument, conversion ratio | 0.00418 |
Debt instrument, conversion price (in USD per share) | $ / shares | $ 239.23 |
Redemption price percentage | 100.00% |
Effective interest rate | 3.69% |
Proceeds allocated to the conversion option (debt discount) | $ 163,800,000 |
Unamortized debt issuance costs | 19,000,000 |
Issuance costs | $ 3,700,000 |
Convertible Debt | Convertible Notes Maturing February 15, 2026 | Debt Conversion Terms One | |
Line of Credit Facility [Line Items] | |
Threshold percentage of stock price trigger | 130.00% |
Threshold of trading days | period | 20 |
Threshold of consecutive trading days | period | 30 |
Convertible Debt | Convertible Notes Maturing February 15, 2026 | Call Option | |
Line of Credit Facility [Line Items] | |
Capped calls, option strike price (in USD per share) | $ / shares | $ 239.23 |
Capped calls, cap price (in USD per share) | $ / shares | $ 362.48 |
Shares covered under call feature | shares | 6.9 |
Capped Call purchase price | $ 81,300,000 |
Debt - Components of Convertibl
Debt - Components of Convertible Debt (Details) $ in Millions | 3 Months Ended | 6 Months Ended |
Dec. 31, 2021USD ($) | Dec. 31, 2021USD ($) | |
Interest Expense, Debt [Abstract] | ||
Amortization of debt discount | $ 7.7 | $ 15.3 |
Amortization of debt issuance costs | 0.8 | 1.6 |
Less: Interest capitalized | (0.2) | (0.2) |
Total interest expense related to the Notes | 8.3 | 16.7 |
Convertible Notes Maturing February 15, 2026 | Convertible Debt | ||
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net [Abstract] | ||
Principal | 1,000 | 1,000 |
Unamortized debt discount | (137.1) | (137.1) |
Unamortized debt issuance costs | (16.2) | (16.2) |
Net carrying amount | $ 846.7 | $ 846.7 |
Debt - Amended and Restated Cre
Debt - Amended and Restated Credit Agreement (Details) - USD ($) | Dec. 10, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Mar. 18, 2021 | Jun. 30, 2019 |
Line of Credit Facility [Line Items] | |||||||
Standby letters of credit outstanding | $ 4,800,000 | $ 4,800,000 | |||||
Revolving Credit Facility | Line of Credit | Amended and Restated Credit Agreement | |||||||
Line of Credit Facility [Line Items] | |||||||
Maximum borrowing capacity | $ 285,000,000 | $ 250,000,000 | |||||
Commitment fees incurred | 300,000 | $ 200,000 | 600,000 | $ 500,000 | |||
Covenant, minimum level of liquidity required | 250,000,000 | 250,000,000 | |||||
Revolving Credit Facility | Line of Credit | Amended and Restated Credit Agreement | Maximum | |||||||
Line of Credit Facility [Line Items] | |||||||
Covenant, minimum level of revenue required | 3,000,000,000 | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | |||||||
Line of Credit Facility [Line Items] | |||||||
Maximum borrowing capacity | $ 500,000,000 | ||||||
Debt issuance costs | 1,100,000 | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | December 10, 2026 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Maximum borrowing capacity | $ 465,000,000 | ||||||
Commitment fee percentage | 0.325% | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | June 20, 2024 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Maximum borrowing capacity | $ 35,000,000 | ||||||
Commitment fee percentage | 0.375% | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | SOFR | December 10, 2026 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Basis spread on variable rate | 2.25% | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | SOFR | June 20, 2024 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Basis spread on variable rate | 2.75% | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | Alternative Base Rate | December 10, 2026 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Basis spread on variable rate | 1.25% | ||||||
Revolving Credit Facility | Line of Credit | Second Amended Credit Agreement | Alternative Base Rate | June 20, 2024 Maturity | |||||||
Line of Credit Facility [Line Items] | |||||||
Basis spread on variable rate | 1.75% | ||||||
Letter of Credit | |||||||
Line of Credit Facility [Line Items] | |||||||
Restricted cash | $ 86,800,000 | $ 86,800,000 | |||||
Letter of Credit | Line of Credit | Amended and Restated Credit Agreement | |||||||
Line of Credit Facility [Line Items] | |||||||
Maximum borrowing capacity (or less) | $ 150,000,000 |
Commitments and Contingencies -
Commitments and Contingencies - Minimum Guarantee Royalty Payments Due (Details) - Royalty Guarantees, Commitments $ in Millions | Dec. 31, 2021USD ($) |
Purchase Obligation, Fiscal Year Maturity [Abstract] | |
2022 (remaining) | $ 8.6 |
2023 | 32.5 |
2024 | 24.6 |
2025 | 6 |
Total | $ 71.8 |
Commitments and Contingencies_2
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Other Commitments [Line Items] | ||||
Content and royalty reserve | $ 10.2 | $ 17.6 | $ 10.2 | $ 17.6 |
Revenue | 1,133.9 | 1,064.8 | 1,939.1 | 1,822.7 |
Cost of revenue | 853.7 | 640 | 1,396.2 | 1,069.2 |
Connected Fitness Products | ||||
Other Commitments [Line Items] | ||||
Revenue | 796.4 | 870.1 | 1,297.4 | 1,471.5 |
Cost of revenue | 745.5 | 562.8 | 1,186.2 | 927 |
Connected Fitness Products | ||||
Other Commitments [Line Items] | ||||
Revenue | 796.4 | 870.1 | 1,297.4 | 1,471.5 |
Cost of revenue | 745.5 | $ 562.8 | 1,186.2 | $ 927 |
Connected Fitness Products | Connected Fitness Products | ||||
Other Commitments [Line Items] | ||||
Cost of revenue | 5.2 | 5.7 | ||
Connected Fitness Products | Sales Returns and Allowances | ||||
Other Commitments [Line Items] | ||||
Revenue | 7.4 | 18.9 | ||
Return reserve liability | 26.7 | 26.7 | ||
Manufactured Product | ||||
Other Commitments [Line Items] | ||||
Purchase obligation | $ 550 | $ 550 | ||
Manufactured Product | Minimum | ||||
Other Commitments [Line Items] | ||||
Purchase commitments, term | 30 days | |||
Manufactured Product | Maximum | ||||
Other Commitments [Line Items] | ||||
Purchase commitments, term | 90 days |
Equity-Based Compensation - Nar
Equity-Based Compensation - Narrative (Details) $ / shares in Units, $ in Millions | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||||
Sep. 30, 2019period | Dec. 31, 2021USD ($)shares | Dec. 31, 2020USD ($) | Dec. 31, 2021USD ($)$ / sharesshares | Aug. 31, 2021$ / sharesshares | Dec. 31, 2020USD ($)$ / shares | Jul. 01, 2021shares | Jul. 01, 2020shares | |
Class of Stock [Line Items] | ||||||||
Aggregate intrinsic value | $ 241.1 | $ 523.4 | ||||||
Weighted-average grant date fair value per option (in dollars per share) | $ / shares | $ 43.15 | $ 36.05 | ||||||
Stock-based compensation expense | $ 71.9 | $ 37.5 | $ 124.8 | $ 67.1 | ||||
Employee Stock Options | ||||||||
Class of Stock [Line Items] | ||||||||
Expected dividend yield | 0.00% | |||||||
Unrecognized stock-based compensation expense | 738.1 | $ 738.1 | ||||||
Unrecognized stock-based compensation expense, period for recognition (in years) | 3 years | |||||||
ESPP | ||||||||
Class of Stock [Line Items] | ||||||||
Expected dividend yield | 0.00% | |||||||
Stock-based compensation expense | 4.6 | $ 2.2 | $ 8.2 | $ 3.8 | ||||
Unrecognized stock-based compensation expense | $ 21.6 | $ 21.6 | ||||||
Unrecognized stock-based compensation expense, period for recognition (in years) | 1 year 6 months | |||||||
ESPP | 2019 Employee Stock Purchase Plan | ||||||||
Class of Stock [Line Items] | ||||||||
Number of purchase periods | period | 4 | |||||||
Purchase period (in months) | 6 months | |||||||
Commencement of offering period (in years) | 2 years | 2 years | 2 years | |||||
Commencement of purchase period (in months) | 6 months | |||||||
Total modification charges to ESPP | $ 3.5 | |||||||
Class A Common Stock | 2019 Equity Incentive Plan | ||||||||
Class of Stock [Line Items] | ||||||||
Increase in number of shares authorized, as a percentage of total common stock outstanding | 5.00% | |||||||
Increase in number of shares available for future issuance (in shares) | shares | 15,007,356 | |||||||
Number of shares available for future issuance (in shares) | shares | 59,172,230 | 59,172,230 | ||||||
Class A Common Stock | ESPP | ||||||||
Class of Stock [Line Items] | ||||||||
Number of shares purchased under ESPP (in shares) | shares | 293,356 | |||||||
Weighted-average price of shares purchased under ESPP (in dollars per share) | $ / shares | $ 39.95 | |||||||
Class A Common Stock | ESPP | 2019 Employee Stock Purchase Plan | ||||||||
Class of Stock [Line Items] | ||||||||
Increase in number of shares authorized, as a percentage of total common stock outstanding | 1.00% | |||||||
Increase in number of shares available for future issuance (in shares) | shares | 3,001,471 | |||||||
Number of shares available for future issuance (in shares) | shares | 10,568,799 | 10,568,799 | ||||||
Purchase price of common stock, percentage of fair market value | 85.00% |
Equity-Based Compensation - Sum
Equity-Based Compensation - Summary of Stock Options Outstanding (Details) - USD ($) $ / shares in Units, $ in Millions | 6 Months Ended | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2021 | |
Stock Options Outstanding, Number of Stock Options | |||
Stock options outstanding, beginning balance (in shares) | 57,946,608 | ||
Granted (in shares) | 3,522,970 | ||
Exercised (in shares) | (3,157,764) | ||
Forfeited (in shares) | (684,266) | ||
Stock options outstanding, ending balance (in shares) | 57,627,548 | 57,946,608 | |
Stock options vested and exercisable (in shares) | 33,141,759 | ||
Stock Options Outstanding, Weighted-Average Exercise Price | |||
Stock options outstanding, weighted average exercise price, beginning balance (in dollars per shares) | $ 18.47 | ||
Granted, weighted-average exercise price (in dollars per share) | 96.07 | ||
Exercised, weighted-average exercise price (in dollars per share) | 9.44 | ||
Forfeited, weighted-average exercise price (in dollars per share) | 58.32 | ||
Stock options outstanding, weighted average exercise price, ending balance (in dollars per shares) | 23.23 | $ 18.47 | |
Stock options vested and exercisable, weighted-average exercise price (in dollars per share) | $ 11.10 | ||
Stock options outstanding, weighted-average remaining contractual term (in years) | 7 years | 7 years 3 months 18 days | |
Stock options vested and exercisable, weighted-average remaining contractual term (in years) | 6 years 2 months 12 days | ||
Stock options outstanding, aggregate intrinsic value | $ 6,119.2 | ||
Stock options exercised, aggregate intrinsic value | 241.1 | $ 523.4 | |
Stock options outstanding, aggregate intrinsic value | 1,226.5 | $ 6,119.2 | |
Stock options vested and exercisable, aggregate intrinsic value | $ 891.2 |
Equity-Based Compensation - S_2
Equity-Based Compensation - Summary of Unvested Stock Option Activity (Details) - $ / shares | 6 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Unvested Options | ||
Unvested options, beginning balance (in shares) | 28,160,034 | |
Granted (in shares) | 3,522,970 | |
Early exercised unvested (in shares) | (13,501) | |
Vested (in shares) | (6,511,747) | |
Forfeited (in shares) | (671,967) | |
Unvested options, ending balance (in shares) | 24,485,789 | |
Unvested Options, Weighted-Average Grant Date Fair Value | ||
Unvested options, weighted-average grant date fair value, beginning balance (in dollars per share) | $ 13.52 | |
Unvested options, weighted-average grant date fair value, granted (in dollars per share) | 43.15 | $ 36.05 |
Unvested options, weighted-average grant date fair value, early exercised unvested (in dollars per share) | 2.02 | |
Unvested options, weighted-average grant date fair value, vested (in dollars per share) | 10.95 | |
Unvested options, weighted-average grant date fair value, forfeited (in dollars per share) | 25.87 | |
Unvested options, weighted-average grant date fair value, ending balance (in dollars per share) | $ 18.13 |
Equity-Based Compensation - S_3
Equity-Based Compensation - Summary of Fair Value Assumptions (Details) | 6 Months Ended |
Dec. 31, 2021 | |
Employee stock options | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Weighted average risk-free interest rate | 1.00% |
Weighted average expected term (in years) | 6 years |
Weighted average expected volatility rate | 47.00% |
Expected dividend yield | 0.00% |
Shares estimated to be purchased under ESPP | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Weighted average risk-free interest rate | 0.50% |
Weighted average expected term (in years) | 1 year 2 months 12 days |
Weighted average expected volatility rate | 64.90% |
Expected dividend yield | 0.00% |
Equity-Based Compensation - S_4
Equity-Based Compensation - Summary of Restricted Stock and Restricted Stock Units (Details) | 6 Months Ended |
Dec. 31, 2021$ / sharesshares | |
Weighted-Average Grant Date Fair Value | |
Outstanding, weighted-average grant date fair value, beginning balance (in dollars per share) | $ / shares | $ 99.43 |
Granted, weighted-average grant date fair value (in dollars per share) | $ / shares | 96.09 |
Vested and converted to shares, weighted-average grant date fair value (in dollars per share) | $ / shares | 99.46 |
Cancelled, weighted-average grant date fair value (in dollars per share) | $ / shares | 105.80 |
Outstanding, weighted-average grant date fair value, ending balance (in dollars per share) | $ / shares | $ 96.77 |
Restricted stock units and awards | |
Number of Awards | |
Outstanding, beginning balance (in shares) | shares | 1,785,946 |
Granted (in shares) | shares | 2,667,778 |
Vested and converted to shares (in shares) | shares | (669,555) |
Cancelled (in shares) | shares | (127,989) |
Outstanding, ending balance (in shares) | shares | 3,656,180 |
Equity-Based Compensation - S_5
Equity-Based Compensation - Summary of Sock-Based Compensation Expense (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 71.9 | $ 37.5 | $ 124.8 | $ 67.1 |
Cost of revenue | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 11.7 | 7.1 | 19.7 | 13 |
Cost of revenue | Connected Fitness Products | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 6.6 | 2 | 11 | 3.5 |
Cost of revenue | Subscription | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 5.1 | 5.1 | 8.7 | 9.5 |
Sales and marketing | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 9 | 4.6 | 21.7 | 8.2 |
General and administrative | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | 38.3 | 21.2 | 15.5 | 8 |
Research and development | ||||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | ||||
Total stock-based compensation expense | $ 12.9 | $ 4.6 | $ 67.8 | $ 37.8 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||||
Income tax (benefit) expense | $ 3.1 | $ (3) | $ 5.4 | $ (1.7) |
Effective tax rate | (0.71%) | (4.60%) | (0.67%) | (1.24%) |
Net (Loss) Income Per Share - S
Net (Loss) Income Per Share - Schedule of Computation of Basic and Diluted net (Loss) Income Per Share (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Basic net (loss) income per share: | ||||
Net (loss) income attributable to common stockholders | $ (439.4) | $ 63.6 | $ (815.3) | $ 132.8 |
Shares used in computation: | ||||
Weighted-average common shares outstanding (in share) | 317,110,297 | 292,462,184 | 309,119,648 | 290,591,037 |
Basic net (loss) income per share (in dollars per share) | $ (1.39) | $ 0.22 | $ (2.64) | $ 0.46 |
Diluted net (loss) income per share: | ||||
Net (loss) income attributable to common stockholders | $ (439.4) | $ 63.6 | $ (815.3) | $ 132.8 |
Weighted-average effect of potentially dilutive securities: | ||||
Diluted weighted-average common shares outstanding (in shares) | 317,110,297 | 347,886,695 | 309,119,648 | 344,994,314 |
Diluted net (loss) income per share (in dollars per share) | $ (1.39) | $ 0.18 | $ (2.64) | $ 0.39 |
Employee stock options | ||||
Weighted-average effect of potentially dilutive securities: | ||||
Weighted-average effect of potentially dilutive securities (in shares) | 0 | 54,271,831 | 0 | 53,426,104 |
Restricted stock units and awards | ||||
Weighted-average effect of potentially dilutive securities: | ||||
Weighted-average effect of potentially dilutive securities (in shares) | 0 | 636,056 | 0 | 552,394 |
Shares estimated to be purchased under ESPP | ||||
Weighted-average effect of potentially dilutive securities: | ||||
Weighted-average effect of potentially dilutive securities (in shares) | 0 | 516,624 | 0 | 424,779 |
Net (Loss) Income Per Share -_2
Net (Loss) Income Per Share - Schedule of Potentially Diluted Securities Not Included In Calculation of Diluted Shares Outstanding (Details) - shares | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Employee stock options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Shares excluded from calculation of diluted shares outstanding (in shares) | 44,011,349 | 65,236 | 47,438,668 | 206,467 |
Restricted stock units and awards | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Shares excluded from calculation of diluted shares outstanding (in shares) | 104,006 | 590 | 252,433 | 6,761 |
Shares estimated to be purchased under ESPP | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Shares excluded from calculation of diluted shares outstanding (in shares) | 0 | 0 | 56,740 | 0 |
Net (Loss) Income Per Share - N
Net (Loss) Income Per Share - Narrative (Details) | Feb. 28, 2021$ / shares |
Convertible Notes Maturing February 15, 2026 | Convertible Debt | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |
Debt instrument, conversion price (in USD per share) | $ 239.23 |
Segment Information - Schedule
Segment Information - Schedule of Key Performance Measures by Segment (Details) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2021USD ($)segment | Dec. 31, 2020USD ($) | |
Segment Reporting [Abstract] | ||||
Number of reportable segments | segment | 2 | |||
Segment Reporting Information [Line Items] | ||||
Revenue | $ 1,133.9 | $ 1,064.8 | $ 1,939.1 | $ 1,822.7 |
Cost of revenue | 853.7 | 640 | 1,396.2 | 1,069.2 |
Gross profit | 280.2 | 424.8 | 543 | 753.5 |
Connected Fitness Products | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 796.4 | 870.1 | 1,297.4 | 1,471.5 |
Cost of revenue | 745.5 | 562.8 | 1,186.2 | 927 |
Gross profit | 51 | 307.3 | 111.3 | 544.5 |
Subscription | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 337.5 | 194.7 | 641.7 | 351.2 |
Cost of revenue | 108.3 | 77.2 | 210 | 142.2 |
Gross profit | $ 229.3 | $ 117.5 | $ 431.7 | $ 209 |
Segment Information - Reconcili
Segment Information - Reconciliation of Segment Gross Profit to Consolidated (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | |
Segment Reporting [Abstract] | ||||
Segment Gross Profit | $ 280.2 | $ 424.8 | $ 543 | $ 753.5 |
Sales and marketing | (349.6) | (177.4) | (633.9) | (292.1) |
General and administrative | (248.7) | (141.1) | (489) | (249.7) |
Research and development | (100) | (47.5) | (197.7) | (84.1) |
Impairment expense | (7.7) | 0 | (7.7) | 0 |
Total other (expense) income, net | (10.6) | 1.8 | (24.6) | 3.5 |
(Loss) income before provision for income taxes | $ (436.3) | $ 60.6 | $ (809.9) | $ 131.2 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Billions | Nov. 16, 2021 | Dec. 31, 2021 | Jun. 30, 2021 |
Over-Allotment Option | |||
Class of Stock [Line Items] | |||
Shares issued in initial public offering (in shares) | 27,173,912 | ||
Price per share in initial public offering (in dollars per share) | $ 46 | ||
Aggregate proceeds received from initial public offering, net of underwriters' discounts and commissions | $ 1.2 | ||
Class A Common Stock | |||
Class of Stock [Line Items] | |||
Common stock, par value (in dollars per share) | $ 0.000025 | $ 0.000025 | |
Class A Common Stock | Over-Allotment Option | |||
Class of Stock [Line Items] | |||
Shares issued in initial public offering (in shares) | 3,260,869 | ||
Common stock, par value (in dollars per share) | $ 0.000025 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) $ in Millions | Feb. 07, 2022 | Feb. 01, 2022 | Dec. 31, 2021 |
Subsequent Event [Line Items] | |||
Options granted (in shares) | 3,522,970 | ||
Subsequent Event | Chief Executive Officer | |||
Subsequent Event [Line Items] | |||
Options granted (in shares) | 8,000,000 | ||
Vesting period | 4 years | ||
February 2022 Restructuring Plan | Subsequent Event | Employee Reduction, Facility Closings, Consolidation of Facilities | |||
Subsequent Event [Line Items] | |||
Expected cost | $ 190 | ||
Severance and other related personnel reduction costs | 90 | ||
Business exit costs | 40 | ||
Capital expenditures | 60 | ||
Asset impairment | 80 | ||
Annualized cost savings | $ 800 |